輸入代號或公司名稱後按 Enter
ELUT

ELUTIA INC.

+0.04 (+4.95%)前一交易日收盤 2026-09-17
美股 · Nasdaq · 製藥生技 · 生物製劑SIC 2836
0.85USD64.4K成交股數37.6M市值0.8本益比(近四季)3.1股價營收比-11.7%營收年增(近四季)2026-11-12下次財報

財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束

逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。

營收與利潤率近 16 季

稀釋 EPS近 16 季 · 美元

現金流近 16 季

股東回饋近 16 季 · 庫藏股與股利

損益表 逐季 · 最新在左 · 小字是年增率

科目26Q226Q125Q325Q225Q124Q424Q324Q224Q123Q323Q223Q1
營收2.4M-18%3.1M-243%3.3M-9%2.7M-56%3.0M-56%−2.2M-136%3.7M-42%6.3M-2%6.7M6.1M6.4M6.4M
營業成本980K1.3M1.5M1.3M1.6M−1.5M1.9M3.5M3.9M3.3M3.6M3.0M
毛利1.4M+5%1.8M-351%1.9M+3%1.5M-48%1.4M-51%−718K-125%1.8M-34%2.8M-17%2.8M2.8M2.7M3.4M
毛利率59.6%57.9%55.8%52.9%46.8%32.9%48.9%44.5%42.5%46.4%42.7%52.8%
研發費用2.5M2.0M1.1M989K871K123K702K1.0M1.2M557K869K1.6M
銷售管理費用3.5M4.1M3.5M3.6M3.7M4.0M4.3M4.7M5.1M2.8M3.9M3.5M
營業利益−8.0M+17%−6.3M+40%−5.2M-43%−8.4M-2%−6.8M-20%−4.5M-38%−9.2M+45%−8.5M+2%−8.5M−7.4M−6.3M−8.3M
營業利益率-327.9%-203.9%-156.7%-304.5%-229.7%208.6%-250.5%-135.3%-126.7%-120.3%-99.3%-130.5%
稅後淨利−7.6M+94%−7.5M-18%−3.9M-401%−9.6M-66%−3.9M-78%−9.1M-7%1.3M-112%−28.2M+253%−18.0M−9.7M−10.6M−8.0M
淨利率-315.0%-239.9%-116.4%-349.8%-133.3%415.6%35.1%-447.9%-268.8%-159.1%-167.2%-124.7%
稀釋 EPS-0.17-19%-0.17-149%-0.19-42%-0.26-77%-0.21-72%0.35-161%-0.33-49%-1.13+131%-0.75-0.57-0.65-0.49
稀釋股數44.2M43.0M47.0M46.3M42.9M29.1M35.5M24.9M23.9M17.0M16.2M16.1M

資產負債表 期末餘額

科目26Q226Q125Q325Q225Q124Q424Q324Q224Q123Q323Q223Q1
現金與約當現金19.9M28.5M4.7M8.5M17.4M13.2M25.7M18.2M12.6M14.5M9.3M11.8M
應收帳款1.4M2.1M3.6M3.2M2.9M2.3M2.9M3.5M4.4M2.9M6.3M7.3M
存貨2.6M2.7M2.0M5.2M4.3M1.9M3.6M3.1M3.1M6.5M9.3M11.1M
總資產43.6M55.2M29.4M33.8M39.3M36.1M48.4M41.9M35.4M54.6M52.3M60.6M
有息負債21.1M21.4M21.8M22.6M22.6M18.9M19.7M25.3M24.9M24.6M
總負債27.9M32.7M73.3M75.7M75.8M82.4M88.6M106M85.7M84.1M74.5M72.8M
股東權益15.7M22.5M−43.9M−41.8M−36.5M−46.3M−40.2M−64.3M−50.3M−29.5M−22.1M−12.2M
負債比63.9%59.2%249.3%223.6%192.8%228.0%183.1%253.5%242.2%154.0%142.3%120.1%
淨現金(現金 − 有息負債)−16.4M−12.9M−4.4M−9.4M3.1M−685K−7.2M−10.8M−15.6M−12.8M

現金流量表 單季

科目26Q226Q125Q325Q225Q124Q424Q324Q224Q123Q323Q223Q1
營業現金流−7.8M−8.9M+236%−2.6M−5.2M
資本支出459K278K15K182K
自由現金流−8.3M−9.2M+245%−2.7M−5.3M
折舊攤銷330K868K864K947K
買回庫藏股
現金股利
自由現金流率-266.2%-310.4%-39.7%-83.7%

營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度

業務分部2025 年度 · 12.3M
Women S Health9.1M74.3%-20.9%
Cardiovascular3.2M25.7%+8.3%

各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。

年度 10-K

財年營收年增稅後淨利淨利率稀釋 EPS自由現金流
FY202512.3M-15.0%53.4M434.2%0.87−46.7M
FY202414.5M-41.5%−53.9M-372.9%-1.86−23.3M
FY202324.7M+3.8%−37.7M-152.2%-2.07−22.1M
FY202223.8M+16.6%−32.9M-137.9%-2.38−22.0M
FY202120.5M-52.1%−24.8M-121.4%-2.38−15.8M
FY202042.7M-0.5%−21.8M-51.1%-8.88−14.3M
FY201942.9M−11.9M-27.8%-18.48−7.8M